This inventor holds 4 USPTO granted patents. Top assignee: The Howard Foundation. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2001
Title: The Innovations of Richard Andrew Bone
Introduction
Richard Andrew Bone is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of retinal health through his innovative patents. With a total of 4 patents, Bone's work focuses on the therapeutic applications of carotenoids in treating retinal disorders.
Latest Patents
Bone's latest patents include groundbreaking formulations for the treatment of retinal disorders. One of his key inventions is the development of meso-zeaxanthin compositions for pharmaceutical use. This invention aims to increase the deposition of macular pigment in the human eye, particularly for the therapeutic treatment or prophylaxis of age-related macular degeneration (AMD). Additionally, he has disclosed the use of pharmaceutically active carotenoids, specifically lutein and zeaxanthin, for the treatment of advanced macular degeneration. These carotenoids are deployed in high dosages to achieve the serum levels necessary for effective uptake by the macula.
Career Highlights
Bone is associated with The Howard Foundation, where he continues to advance research in retinal health. His work has been instrumental in developing new therapeutic strategies for combating macular degeneration, a leading cause of vision loss.
Collaborations
Throughout his career, Bone has collaborated with esteemed colleagues such as John T. Landrum and Alan Norman Howard. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Richard Andrew Bone's contributions to the field of retinal health through his innovative patents highlight his commitment to improving vision care. His work continues to pave the way for new treatments that can significantly impact the lives of those affected by retinal disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile